Roberta Sarmiento
Impact in
- Pharmacology top 10%
- Inflammatory mediators and NSAID effects
-
- Cancer, Lipids, and Metabolism
Papers in
- Oncology 9
- Cancer Treatment and Pharmacology 4
- Colorectal Cancer Treatments and Studies 3
- HER2/EGFR in Cancer Research 2
-
- Angiogenesis and VEGF in Cancer 6
- Co-authors
- Giampietro Gasparini (20 shared papers)Alessandro Morabito (6 shared papers)Raffaele Longo (8 shared papers)Domenico Gattuso (7 shared papers)Massimo Fanelli (5 shared papers)Guido Carillio (4 shared papers)Mario D’Andrea (2 shared papers)Francesco Torino (2 shared papers)
In The Last Decade
Roberta Sarmiento
20 papers receiving 600 citations
Peers
Comparison fields: 5 of 70
- Pharmacology 151
- Cancer Research 115
- Oncology 199
- Immunology 76
- Toxicology 11
Countries citing papers authored by Roberta Sarmiento
This map shows the geographic impact of Roberta Sarmiento's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta Sarmiento with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta Sarmiento more than expected).
Fields of papers citing papers by Roberta Sarmiento
This network shows the impact of papers produced by Roberta Sarmiento. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta Sarmiento. The network helps show where Roberta Sarmiento may publish in the future.
Co-authors
The 25 scholars most cited alongside Roberta Sarmiento, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 300 | |
| 2 | 2015 | 70 | |
| 3 | 2004 | 34 | |
| 4 | 2003 | 30 | |
| 5 | 2003 | 30 | |
| 6 | 2010 | 25 | |
| 7 | 2004 | 24 | |
| 8 | 2004 | 23 | |
| 9 | 2000 | 22 | |
| 10 | 2005 | 20 | |
| 11 | 2011 | 12 | |
| 12 | Antiangiogenic therapies in breast cancer. | 2009 | 9 |
| 13 | 2013 | 7 | |
| 14 | 2012 | 5 | |
| 15 | 2003 | 4 | |
| 16 | 2006 | 2 | |
| 17 | 2014 | 1 | |
| 18 | 2006 | 1 | |
| 19 | Antiangiogenic agents. | 2002 | 1 |
| 20 | 2003 | 1 |
About Roberta Sarmiento
Roberta Sarmiento is a scholar working on Oncology, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine and Pharmacology, having authored 21 papers that have together received 621 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (6 papers), Cancer Treatment and Pharmacology (4 papers), Inflammatory mediators and NSAID effects (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Multiple Myeloma Research and Treatments (3 papers), Cancer, Lipids, and Metabolism (2 papers), Breast Cancer Treatment Studies (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Pharmacology (151 citations), Cancer Research (115 citations), Oncology (199 citations), Immunology (76 citations) and Toxicology (11 citations). Roberta Sarmiento has collaborated with scholars based in Italy, Germany and Belgium. Frequent co-authors include Giampietro Gasparini, Alessandro Morabito, Raffaele Longo, Domenico Gattuso, Massimo Fanelli, Guido Carillio, Mario D’Andrea, Francesco Torino, Luigi Mariani and Robin Schmitz. Their work appears in journals such as Expert Opinion on Investigational Drugs, Critical Reviews in Oncology/Hematology, The Oncologist, Blood and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.